Literature DB >> 19789447

Why we should be wary of single-center trials.

Rinaldo Bellomo1, Stephen J Warrillow, Michael C Reade.   

Abstract

OBJECTIVES: To highlight the limitations of single-center trials in critical care, using prominent examples from the recent literature; to explore possible reasons for discrepancies between these studies and subsequent multicenter effectiveness trials; and to suggest how the evidence from single-center trials might be used more appropriately in clinical practice. STUDY SELECTION: Topical and illustrative examples of the concepts discussed including trials of patient positioning, the use of steroids for acute respiratory distress syndrome, the dose of hemofiltration, the control of glycemia, and the targets of resuscitation in sepsis. DATA SYNOPSIS: Many positive single-center trials have been contradicted when tested in other settings and, in one case, the subsequent definitive multicentered trial has found a previously recommended intervention associated with active harm. Problems inherent in the nature of single-center studies make recommendations based on their results ill advised. Single-center studies frequently either lack the scientific rigor or external validity required to support widespread changes in practice, and their premature incorporation into guidelines may make the conduct of definitive studies more difficult.
CONCLUSIONS: We recommend that practice guidelines should rarely, if ever, be based on evidence from single-center trials. Physicians should apply the findings of single-center trials only after careful evaluation of their methodology, and in particular after comparing the context of the trial with their own situation.

Entities:  

Mesh:

Year:  2009        PMID: 19789447     DOI: 10.1097/CCM.0b013e3181bc7bd5

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  67 in total

Review 1.  Evaluation of coma: a critical appraisal of popular scoring systems.

Authors:  Joshua Kornbluth; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

Review 2.  Coagulopathy and transfusion strategies in trauma. Overwhelmed by literature, supported by weak evidence.

Authors:  Daniele Poole
Journal:  Blood Transfus       Date:  2015-11-20       Impact factor: 3.443

Review 3.  Exercise for improving age-related hyperkyphotic posture: a systematic review.

Authors:  Symron Bansal; Wendy B Katzman; Lora M Giangregorio
Journal:  Arch Phys Med Rehabil       Date:  2013-07-09       Impact factor: 3.966

4.  Unplanned Transfers from Hospital Wards to the Neurological Intensive Care Unit.

Authors:  C A Gold; S A Mayer; L Lennihan; J Claassen; J Z Willey
Journal:  Neurocrit Care       Date:  2015-10       Impact factor: 3.210

Review 5.  The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease.

Authors:  James D Lewis; Lindsey Albenberg; Dale Lee; Mario Kratz; Klaus Gottlieb; Walter Reinisch
Journal:  Inflamm Bowel Dis       Date:  2017-02       Impact factor: 5.325

Review 6.  A decade of evolution in Indonesian orthopedic publication: A bibliographic report.

Authors:  Yoshi Pratama Djaja; Renaldi Prasetia; Asep Santoso; Ahmad Jabir Rahyussalim; Edi Mustamsir; Ismail Hadisoebroto Dilogo
Journal:  J Clin Orthop Trauma       Date:  2020-10-12

Review 7.  A seat at the table: an invitation to the SRS podium via the study group.

Authors:  Joshua T Bram; Heidi R Nocka; Patrick J Cahill; John M Flynn; Jason B Anari
Journal:  Spine Deform       Date:  2021-01-27

8.  Low dose dexmedetomidine for the prophylaxis of perioperative ICU delirium-how much evidence is enough?

Authors:  Michael C Reade
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 9.  Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective.

Authors:  John L Moran; Petra L Graham; Sue Rockliff; Andrew D Bersten
Journal:  Crit Care       Date:  2010-07-13       Impact factor: 9.097

10.  Randomized clinical trial of zoledronic acid in multiple myeloma patients undergoing high-dose chemotherapy and stem-cell transplantation.

Authors:  A Avilés; N Neri; J Huerta-Guzmán; M J Nambo
Journal:  Curr Oncol       Date:  2013-02       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.